Foamix Pharmaceuticals (NASDAQ:FOMX), together with licensee LEO Pharma A/S, has settled patent infringement litigation with an affiliate of Teva Pharmaceutical Industries (NYSE:TEVA) regarding topical rosacea med Finacea Foam. Financial details remain confidential.
Its patent infringement dispute (same product) with Taro Pharmaceuticals U.S.A. and Taro Pharmaceuticals, Ltd. continues.
Shares up 6% premarket on increased volume.
https://seekingalpha.com/news/3507191-foamix-settles-patent-dispute-teva-shares-6-percent-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.